# Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients with <i>RAS</i> mutant solid tumors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/abstract-ct046-phase-i-dose-escalation-study-of-the-cdk4-6-inhibitor-palbociclib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Geoffrey I. Shapiro,John Hilton,Leena Gandi,Nicole G. Chau,James M. Cleary,Andrew Wolanski,Adrienne Anderson,Brian Beardslee,Faith Hassinger,Ketki Bhushan,Elizabeth Downey,Joseph Gibson,Solida Pruitt-Thompson,Alona Muzikansky,Suzanne Barry,Nora Feeney,Cloud P. Paweletz,Geoffrey R. Oxnard,Jeffrey G. Supko,Pasi A. Jänne,Kwok‐Kin Wong,Bruce E. Johnson |
| Citations | 10 |
| DOI | 10.1158/1538-7445.am2017-ct046 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2741548122 |
| Type | conference-abstract |
| Year | 2017 |

## Paper authors

- [Nora Feeney](https://scholariq.org/researchers/nora-feeney/)

## Paper journal

- [Cancer Research](https://scholariq.org/journals/cancer-research/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.